0268 0269 COVID19 controls

MassCheck® COVID-19 Drugs Plasma Controls

   
  • Azithromycin
  • Chloroquine
  • Favipiravir
  • GS 441524
  • Hydroxychloroquine
  • Lopinavir
  • Nafamostat
  • Remdesivir
  • Ritonavir

Order no.: 0268, 0269

Product Name Qty
MassCheck® COVID-19 Drugs Plasma Control, Level I
Order no.: 0268
MassCheck® COVID-19 Drugs Plasma Control, Level II
Order no.: 0269

Description

MassCheck® COVID-19 Drugs Plasma Controls, lyophilised.

0268 MassCheck® COVID-19 Drugs Plasma Control, Level I (lyoph.), 5 x 1 ml
0269 MassCheck® COVID-19 Drugs Plasma Control, Level II (lyoph.), 5 x 1 ml

These lyophilised quality controls from Chromsystems are for research-use only and not for diagnostic purposes. They are based on human plasma and should be used according to the product inserts. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.

Technical Data

Method of Analysis

LC-MS/MS

Parameter

Azithromycin, Chloroquine, Favipiravir, GS 441524, Hydroxychloroquine, Lopinavir, Nafamostat, Remdesivir, Ritonavir

Concentrations

Please note: All concentrations shown here are exemplatory. They do not reflect real data for the described products. Actual concentrations depend on the production lot of each product and can exclusively be found in the product information leaflet. Please ask for these product information leaflets or download them from the service site of the Chromsystems website.

SubstanceTarget Value [µg/l
Level I
Range [µg/l]
Level I
Target Value [µg/l]
Level II
Range [µg/l]
Level II
Azithromycin 151 121-182 357 286-428
Chloroquine 110 88-133 352 282-423
Favipiravir 2678 2143-3214 7987 6389-9584
Lopinavir 1070 856-1284 4967 3974-5960
Nafamostat 45.0 36-54 167 133-200
Hydroxychloroquine 463 370-555 943 755-1132
GS 441524 35.3 28.3-42.4 67.4 53.9-80.9
Remdesivir 727 582-873 2131 1704-2557
Ritonavir 768 614-921 4945 3956-5934

Manual

These Chromsystems plasma controls are designed to monitor the accuracy and precision of analytical procedures for the quantitative determination of COVID-19 drugs in serum/plasma. The lyophilised control is based on human plasma and should be used routinely according to the instructions of the assay procedure being used. While following these instructions the control is to be handled in the same manner as a patient specimen.

Reconstitution

Carefully remove the rubber stopper from the vial. Add exactly 1.0 ml of distilled water into the vial. Replace the stopper and allow to sit for 10 to 15 minutes at room temperature. Swirl the vial to dissolve the contents until homogeneity.

Storage conditions

Stored below -18 °C unopened controls are stable until the expiry date which is stated on the vial labels. The reconstituted control can be stored up to three days tightly capped at +2 to +8 °C. If the controls cannot be analysed within this period, they should be aliquoted and stored frozen below –18 °C (up to 1 month).